Publications

absence of mers-coronavirus in bactrian camels, southern mongolia, november 2014.		2015	26080032
absence of middle east respiratory syndrome coronavirus in bactrian camels in the west inner mongolia autonomous region of china: surveillance study results from july 2015.		2015	26632875
absence of middle east respiratory syndrome coronavirus in camelids, kazakhstan, 2015.		2016	26889787
bactrian camels shed large quantities of middle east respiratory syndrome coronavirus (mers-cov) after experimental infection.	in 2012, middle east respiratory syndrome coronavirus (mers-cov) emerged. to date, more than 2300 cases have been reported, with an approximate case fatality rate of 35%. epidemiological investigations identified dromedary camels as the source of mers-cov zoonotic transmission and evidence of mers-cov circulation has been observed throughout the original range of distribution. other new-world camelids, alpacas and llamas, are also susceptible to mers-cov infection. currently, it is unknown wheth ...	2019	31119984
middle east respiratory syndrome coronavirus antibodies in bactrian and hybrid camels from dubai.	so far, dromedary camels are the only known animal reservoir for middle east respiratory syndrome (mers) coronavirus (mers-cov). previous published serological studies showed that sera of bactrian camels were all negative for mers-cov antibodies. however, a recent study revealed that direct inoculation of bactrian camels intranasally with mers-cov can lead to infection with abundant virus shedding and seroconversion. in this study, we examined the presence of mers-cov antibodies in bactrian and ...	2020	31969478
newcastle disease virus-based mers-cov candidate vaccine elicits high-level and lasting neutralizing antibodies in bactrian camels.	middle east respiratory syndrome coronavirus (mers-cov), a member of the coronaviridae family, is the causative pathogen for mers that is characterized by high fever, pneumonia, acute respiratory distress syndrome (ards), as well as extrapulmonary manifestations. currently, there are no approved treatment regimens or vaccines for mers. here, we generated recombinant nonvirulent newcastle disease virus (ndv) lasota strain expressing mers-cov s protein (designated as rla-mers-s), and evaluated its ...	2017	32288953